Gill Dalvir, Feldman Elizabeth A, Liu Kan
Department of Internal Medicine (Gill), Department of Pharmacy (Feldman), and Division of Cardiology (Liu), State University of New York Upstate Medical University, Syracuse, New York.
Proc (Bayl Univ Med Cent). 2017 Oct;30(4):410-412. doi: 10.1080/08998280.2017.11930208.
To prevent recurrence of acute coronary syndrome (ACS), national practice guidelines recommend use of five-drug combination therapy. Our study assessed the proportion of patients discharged on all five medications following ACS and determined reasons for nonadherence. A retrospective, single-center chart review was conducted at a tertiary academic medical center. Patients 18 years and older who were admitted to the cardiac care unit with a diagnosis of ACS between January 2013 and January 2015 were included. Overall, 200 patients were screened and 155 were included in the study. Half of the patients received all guideline-recommended classes of pharmacological agents at discharge. The other half-78 patients-did not receive the five-drug combination, of whom 48 (62%) had reasons documented for nonadherence. Our study's findings suggest that rates of adherence need to improve given the clear benefits of these medications.
为预防急性冠状动脉综合征(ACS)复发,国家实践指南推荐使用五药联合疗法。我们的研究评估了ACS患者出院时服用全部五种药物的比例,并确定了不依从的原因。在一家三级学术医疗中心进行了一项回顾性单中心病历审查。纳入了2013年1月至2015年1月期间因ACS诊断入住心脏监护病房的18岁及以上患者。总体而言,筛选了200名患者,155名患者纳入研究。一半的患者在出院时接受了所有指南推荐的药物类别。另一半——78名患者——未接受五药联合治疗,其中48名(62%)有记录在案的不依从原因。我们研究的结果表明,鉴于这些药物的明显益处,依从率需要提高。